1. Moridi I, Chen A, Tal O, Tal R. The Association between Vitamin D and Anti-Müllerian Hormone: A Systematic Review and Meta-Analysis. Nutrients. 2020 Jun; 12(6): 1567. Published online 2020 May 28. doi: 10.3390/nu12061567.
2. Irani M, Merhi Z. Role of vitamin D in ovarian physiology and ist implication in reproduction: a systematic review. Fertil Steril 2014;102(2):460-468.
3. Johnson LE, DeLuca HF. Reproductive defects are corrected in vitamin D-deficient female rats fed a high calcium, phosphorus and lactose diet. J Nutr. 2002;132:2270–3.
4. Fabris A, Pacheco A, Cruz M, Puente JM, Fatemi H, Garcia-Velasco JA. Impact of circulating levels of total and bioavailable serum vitamin D on pregnancy rate in egg donation recipients. Fertil Steril 2014;102:1608–1612.
5. Polyzos NP, Anckaert E, Guzman L, Schiettecatte J, Van Landuyt L, Camus M, Smitz J, Tournaye H. Vitamin D deficiency and pregnancy rates in women undergoing single embryo, blastocyst stage, transfer (SET) for IVF/ICSI. Hum Reprod 2014;29:2032–2040.
6. Franasiak JM, Molinaro TA, Dubell EK, Scott KL, Ruiz AR, Forman EJ, Werner MD, Hong KH, Scott RT Jr. Vitamin D levels do not affect IVF outcomes following the transfer of euploid blastocysts. Am J Obstet Gynecol 2015;212:315 e311–e316
7. Van de Vijver A, Drakopoulos P, van Landuyt L, Vaiarelli A, Blockeel C, Santos-Riberiro S, Tournaye H, Polyzos NP. Vitamin D deficiency and pregnancy rates following frozen-thawed embryo transfer: a prospective cohort study. Hum Reprod 2016;31(8):1749-54.
8. Voulgaris N, Papanastasiou L, Piaditis G, Angelousi A, Kaltsas G, Mastorakos G, Kassi E. Vitamin D and aspects of female fertility. Hormones (Athens). 2017 Jan;16(1):5-21. doi: 10.14310/horm.2002.1715. Review
9. Anastasi E, Fuggetta E, De Vito C, Migliara G, Viggiani V, Manganaro L, Granato T, Benedetti Panici P, Angeloni A, Porpora MG. Low levels of 25-OH vitamin D in women with endometriosis and associated pelvic pain. Clin Chem Lab Med. 2017 Apr 28. pii: /j/cclm.ahead-of-print/cclm-2017-0016/cclm-2017-0016.xml. doi: 10.1515/cclm-2017-0016.
10. Kinuta K, Tanaka H, Moriwake T, Aya K, Kato S, Seino Y. Vitamin D is an important factor in estrogen biosynthesis of both female and male gonads. Endocrinology 2000;141:1317–1324.
11. Hurley WL, Doane RM. Recent developments in the roles of vitamins and minerals in reproduction. J Dairy Sci 1989;72:784-804.
12. Bacopoulou F, Kolias E, Efthymiou V, Antonopoulos CN, Charmandari E. Vitamin D predictors in polycystic ovary syndrome: a meta-analysis. Eur J Clin Invest. 2017 Oct;47(10):746-755. doi: 10.1111/eci.12800. Epub 2017 Sep 7.
13. Bahrami A, Avan A, Sadeghnia HR, Esmaeili H, Tayefi M, Ghasemi F, Nejati Salehkhani F, Arabpour-Dahoue M, Rastgar-Moghadam A, Ferns GA, Bahrami-Taghanaki H, Ghayour-Mobarhan M. High dose vitamin D supplementation can improve menstrual problems, dysmenorrhea, and premenstrual syndrome in adolescents. Gynecol Endocrinol. 2018 Feb 15:1-5.
14. Barrera, D.; Avila, E.; Hernandez, G.; Halhali, A.; Biruete, B.; Larrea, F.; Diaz, L. Estradiol and progesterone synthesis in human placenta is stimulated by calcitriol. 1. Steroid Biochem. Mol. Biol. 2007, 103, 529–532.
15. Arabian S, Raoofi Z. Effect of serum vitamin D level on endometrial thickness and parameters of follicle growth in infertile women undergoing induction of ovulation. J Obstet Gynaecol. 2018 Mar 12:1-3.
16. Seifer, D.B.; Maclaughlin, D.T. Mullerian Inhibiting Substance is an ovarian growth factor of emerging clinical significance. Fertil. Steril. 2007, 88, 539–546.
17. Tal, R.; Seifer, D.B. Ovarian reserve testing: A user’s guide. Am. J. Obstet. Gynecol. 2017, 217, 129–140.
18. Dennis NA, Houghton LA, Jones GT, van Rji AM, Morgan K, McLennan IS. The level of serum anti-Müllerian hormone correlates with vitamin D status in men and women but not in boys. J Clin Endocrinol Metabol 2012;97:2450-2455.
19. Krishnan AV, Moreno J, Nonn L, Malloy P, Swami S, Peng L, Peehl DM, Feldman D. Novel pathways that contribute to the anti-proliferative and chemopreventive activities of calcitriol in prostate cancer. J. Steroid Biochem. Mol. Biol. 2007, 103, 694–702.
20. Malloy PJ, Peng L,Wang J, Feldman D. Interaction of the vitamin D receptor with a vitamin D response element in the Mullerian-inhibiting substance (MIS) promoter: regulation of MIS expression by calcitriol in prostate cancer cells. Endocrinology 2009;150:1580–1587.
21. Pearce K, Gleeson K, Tremellen K. Serum anti-Mullerian hormone production is not correlates with seasonal fluctuations of vitamin D status in ovulatory or PCOS women. Hum Reprod 2015;30(9):217.
22. Dennis, N.A.; Houghton, L.A.; Pankhurst, M.W.; Harper, M.J.; McLennan, I.S. Acute Supplementation with High Dose Vitamin D3 Increases Serum Anti-Mullerian Hormone in Young Women. Nutrients 2017, 9, 71.
23. Merhi ZO, Seifer DB, Weedon J, Adeyemi O, Holman S, Anastos K, Golub ET, Young M, Karim R, Greenblatt R.. Circulating vitamin D correlates with serum antimullerian hormone levels in late-reproductive-aged women: Women’s Interagency HIV Study. Fertil. Steril. 2012, 98, 228–234.
24. Jukic AMZ, Baird DD, Wilcox AJ, Weinberg CR, Steiner AZ. 25-Hydroxyvitamin D (25(OH)D) and biomarkers of ovarian reserve. Menopause 2018, 25, 811–816.
25. Wong HYQ, Li HWR, Lam KSL, Tam S, Shek,CC, Lee CYV, Yeung WSB, Ho PC, Ng EHY. Independent association of serum vitamin D with anti-Mullerian hormone levels in women with polycystic ovary syndrome. Clin. Endocrinol. 2018, 89, 634–641.
26. Chang EM, Kim YS, Won HJ, Yoon TK, Lee WS. Association between sex steroids, ovarian reserve, and vitamin D levels in healthy nonobese women. J. Clin. Endocrinol. Metab. 2014, 99, 2526–2532.
27. Kim S, Kim JJ, Kim MJ, Han KH, Lee JR, Suh CS, Choi YM, Kim SH. Relationship between serum anti-Mullerian hormone with vitamin D and metabolic syndrome risk factors in late reproductive-age women. Gynecol. Endocrinol. 2018, 34, 327–331.
28. Purdue-Smithe AC, Whitcomb BW, Manson JE, Hankinson SE, Troy LM, Rosner BA, Bertone-Johnson ER. Vitamin D Status Is Not Associated with Risk of Early Menopause. J. Nutr. 2018, 148, 1445–1452.
29. Szafarowska M, Dziech E, Kaleta B, Kniotek M, Rogowski A, Segiet-Swiecicka A, Jerzak M. Anti-Mullerian hormone level is associated with vitamin D receptor polymorphisms in women with polycystic ovary syndrome. 1. Assist. Reprod. Genet. 2019, 36, 1281–1289.
30. Neville G, Martyn F, Kilbane M, O'Riordan M, Wingfield M, McKenna M, McAuliffe FM. Vitamin D status and fertility outcomes during winter among couples undergoing in vitro fertilization/intracytoplasmic sperm injection. Int J Gynaecol Obstet. 2016 Nov;135(2):172-176.
31. Drakopoulos P, van de Vijver A, Schutyser V, Milatovic S, Anckaert E, Schiettecatte J, Blockeel C, Camus M, Tournaye H, Polyzos NP. The effect of sesrum vitamin D levels on ovarian reserve markers: a prospective cross-sectional study. Hum Reprod 2017;32:208-214.
32. Lata I, Tiwar, S, Gupta A, Yadav S, Yadav S. To Study the Vitamin D Levels in Infertile Females and Correlation of Vitamin D Deficiency with AMH Levels in Comparison to Fertile Females. 1. Hum. Reprod. Sci. 2017, 10, 86–90.
33. Bednarska-Czerwinska A, Olszak-Wasik K, Olejek A, Czerwinski M, Tukiendorf AA. Vitamin D and Anti-Mullerian Hormone Levels in Infertility Treatment: The Change-Point Problem. Nutrients 2019, 11, 1053.
34. Liu, X, Zhang W, Xu Y, Chu Y, Wang X, Li Q, Ma Z, Liu Z, Wan Y. Effect of vitamin D status on normal fertilization rate following in vitro fertilization. Reprod. Biol. Endocrinol. 2019, 17, 59.
35. Lerchbaum E, Theiler-Schwetz V, Kollmann M, Wöfler M, Pilz S, Obermayer-Pietsch B, Trummer C.Effects of Vitamin D Supplementation on Surrogate Markers of Fertility in PCOS Women: A Randomized Controlled Trial. Nutrients 2021, 13(2), 547; doi.org/10.3390/nu13020547.
36. Rogenhofer N, Mischitz D, Mann C, Gluderer J, von Schönfeldt V, Jeschke U, Thaler CJ. Correlation of vitamin D3 (calcitriol) serum concentrations with vitamin B12 and folic acid in women undergoing IVF/ICSI. Gynecol Obstet Invest. 2019 Sep 25:1-8. doi: 10.1159/000493138.
37. Rotterdam ESHRE ⁄ ASRM-Sponsored PCOS Consensus Workshop Group: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81(1):19-25.
38. Mehrafza M, Asgharnia M, Raoufi A, Hosseinzadeh E, Samadnia S, Roushan ZA. The effect of seasonality on reproductive outcome of patients undergoing intracytoplasmic sperm injection: A descriptive cross-sectional study.Int J Reprod Biomed. 2020 Nov; 18(11): 989–994. Published online 2020 Nov 22. doi: 10.18502/ijrm.v13i11.7967.
39. Broer S, Broekmans F, Laven J, Bart C J M Fauser B. Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications. Hum Reprod Update . Sep-Oct 2014;20(5):688-701. doi: 10.1093/humupd/dmu020. Epub 2014 May 12.
40. Bertone-Johnson E, Manson J, Purdue-Smithe A, Steiner A, Eliassen AH, Hankinson SE, Rosner BA, Whitcomb BW. Anti-Müllerian hormone levels and incidence of early natural menopause in a prospective study. Hum Reprod. 2018 Jun; 33(6): 1175–1182.
41. Gold EB. The Timing of the Age at Which Natural Menopause Occurs.Obstet Gynecol Clin North Am. Author manuscript; available in PMC 2012 Sep 1.Published in final edited form as: Obstet Gynecol Clin North Am. 2011 Sep; 38(3): 425–440.
42. Tal, R.; Seifer, D.B. Potential mechanisms for racial and ethnic differences in antimullerian hormone and ovarian reserve. Int. 1. Endocrinol. 2013, 2013, 818912.
43. Shalini Umarsingh, Jamila Khatoon Adam, Suresh Babu Naidu Krishna. The relationship between anti-Müllerian hormone (AMH) levels and pregnancy outcomes in patients undergoing assisted reproductive techniques (ART). PeerJ. 2020; 8: e10390. Published online 2020 Dec 22. doi: 10.7717/peerj.10390.
44. Liu Xitong , Bai H , Mol BW , Shi W, Gao M , Shi J. Seasonal variability does not impact in vitro fertilization success. Sci Rep . 2019 Nov 20;9(1):17185. doi: 10.1038/s41598-019-53919-3.
45. Bodnar LM, Catov JM, Simhan HN, Holick MF, Powers RW, Roberts JM. Maternal vitamin D deficiency increases the risk of preeclampsia. Journal of Clinical Endocrinology and Metabolism. 2007;92(9):3517-22.